![137712-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/137712-Thumbnail%20Image.png?versionId=cPQfZnkp1jvdPd7szRcNajVjTlJUsCOU&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T054924Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=b1bba02d606b04f8a9146ef9f3848ed1fdc965726b1c6ee7892cefcb496fbb50&itok=8kJcAaxA)
![137727-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/137727-Thumbnail%20Image.png?versionId=bJ39H8izbbGkJOBhSaJ5PDoZohhRT7hT&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240614/us-west-2/s3/aws4_request&X-Amz-Date=20240614T194343Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=5c87d9c11d54adae74dda918cee2c402a66cd336803cc439c727b71199c3790a&itok=onenVWzC)
![149595-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/149595-Thumbnail%20Image.png?versionId=PIy03IE3QW9bVxulBhrJCLNVaqthSqO8&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T062349Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=e644e6c0abc6392270ddcd64d3a30ffa9687f7c1e4dc99e144aaa5152716ddeb&itok=MMuVr8ql)
![136304-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136304-Thumbnail%20Image.png?versionId=BYR6ZZH5gRZSm2CjZW44LUTksdH.Ry73&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T033410Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=77802fa31ca5f2188e5b99e848834f63f38f9c9e11a424dd2f8f9139e179f425&itok=CAV21Yn3)
![130366-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/130366-Thumbnail%20Image.png?versionId=Y3UFsAqEPFLGR1T0ZQLJRZ.sD6BFOtMt&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240605/us-west-2/s3/aws4_request&X-Amz-Date=20240605T194838Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=718c194d50060ecbf7fd1c1a1829bc11b4c67ad11f1dacf98718f9a82e48c8c2&itok=6MENkW_C)
The purpose of this study is to determine the feasibility of three widely used wearable sensors in research settings for 24 h monitoring of sleep, sedentary, and active behaviors in middle-aged women.
Methods
Participants were 21 inactive, overweight (M Body Mass Index (BMI) = 29.27 ± 7.43) women, 30 to 64 years (M = 45.31 ± 9.67). Women were instructed to wear each sensor on the non-dominant hip (ActiGraph GT3X+), wrist (GENEActiv), or upper arm (BodyMedia SenseWear Mini) for 24 h/day and record daily wake and bed times for one week over the course of three consecutive weeks. Women received feedback about their daily physical activity and sleep behaviors. Feasibility (i.e., acceptability and demand) was measured using surveys, interviews, and wear time.
Results
Women felt the GENEActiv (94.7 %) and SenseWear Mini (90.0 %) were easier to wear and preferred the placement (68.4, 80 % respectively) as compared to the ActiGraph (42.9, 47.6 % respectively). Mean wear time on valid days was similar across sensors (ActiGraph: M = 918.8 ± 115.0 min; GENEActiv: M = 949.3 ± 86.6; SenseWear: M = 928.0 ± 101.8) and well above other studies using wake time only protocols. Informational feedback was the biggest motivator, while appearance, comfort, and inconvenience were the biggest barriers to wearing sensors. Wear time was valid on 93.9 % (ActiGraph), 100 % (GENEActiv), and 95.2 % (SenseWear) of eligible days. 61.9, 95.2, and 71.4 % of participants had seven valid days of data for the ActiGraph, GENEActiv, and SenseWear, respectively.
Conclusion
Twenty-four hour monitoring over seven consecutive days is a feasible approach in middle-aged women. Researchers should consider participant acceptability and demand, in addition to validity and reliability, when choosing a wearable sensor. More research is needed across populations and study designs.
![131287-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/131287-Thumbnail%20Image.png?versionId=T6jJwczZvIGRrtdooFJZ.tdRkJS3TIz0&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T231202Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=772284f7a02a88b8ee80f82dc7798b41d2d16c406047c5bf9102786df42f5a75&itok=LTN3WMp9)
![132294-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/132294-Thumbnail%20Image.png?versionId=R9WEQArUxfugsXj8W3raohvWrq90rEyN&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T161821Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=a176afe680f8644379516540efb460afaf977f10eee7828b145db9eef5f6334d&itok=kcGmUUKT)
![132036-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/132036-Thumbnail%20Image.png?versionId=KQGdpYL3BoghTH2BXXa8A.cGZbd7Baaa&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T145928Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=6d0d59a03b6d789fdeaee1db42f83535c8b6c08728e41ffc18fc0852bb188cee&itok=jwlr83mm)
![131736-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/131736-Thumbnail%20Image.png?versionId=s_QyI5fJ.6rJncGdVovGAAkzXcOJkW.c&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T163209Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=f706f172358f5f74fa8b2f6cf347434759b33505dd5ceb2352c580cd64a67590&itok=2rg56gud)
![131610-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/131610-Thumbnail%20Image.png?versionId=I7d3FFD9VuHqVV_o88k.Tltj1PbD70Wn&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T163209Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=f24c6b93e0732ebacf51662a06b7f47eb84b20362cfb00db1b82931daf501a75&itok=vGEero8U)
The combined use of methamphetamine and opioids has been reported to be on the rise throughout the United States (U.S.). However, our knowledge of this phenomenon is largely based upon reported overdoses and overdose-related deaths, law enforcement seizures, and drug treatment records; data that are often slow, restricted, and only track a portion of the population participating in drug consumption activities. As an alternative, wastewater-based epidemiology (WBE) has the capability to track licit and illicit drug trends within an entire community, at a low cost and in near real-time, while providing anonymity to those contributing to the sewer shed. In this study, wastewater was collected from two Midwestern U.S. cities (2017-2019) and analyzed for the prevalence of methamphetamine and the opioids oxycodone, codeine, fentanyl, tramadol, hydrocodone, and hydromorphone. Monthly 24-hour time-weighted composite samples (n = 48) from each city were analyzed using isotope dilution liquid chromatography tandem mass spectrometry. Results showed that methamphetamine and total opioid consumption (milligram morphine equivalents) in City 1 were strongly correlated only in 2017 (Spearman rank order correlation coefficient, ρ = 0.78), the relationship driven by fentanyl, hydrocodone, and hydromorphone. For City 2, methamphetamine and total opioid consumption were strongly positively correlated during the entire study (ρ = 0.54), with the correlations driven by hydrocodone and hydromorphone. In both cities, hydrocodone and hydromorphone mass loads were highly correlated, suggesting a parent and metabolite relationship. WBE provides important insights into licit and illicit drug consumption patterns in near real-time as they evolve; important information for community stakeholders in municipalities across the U.S.